2008-09-18
Polymorphisms in folate-related genes: Association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia
Publication
Publication
Leukemia , Volume 22 - Issue 9 p. 1798- 1800
Additional Metadata | |
---|---|
5, 10 methylenetetrahydrofolate reductase (FADH2), DNA polymorphism, acute lymphoblastic leukemia, article, cancer chemotherapy, child, childhood leukemia, clinical protocol, continuous infusion, controlled study, cytarabine, data analysis, drug megadose, folate metabolism, folic acid, folinic acid, genotype, glycine hydroxymethyltransferase, human, infection, liver toxicity, major clinical study, methionine synthase, methotrexate, methylenetetrahydrofolate dehydrogenase, mucosa inflammation, multiple cycle treatment, patient coding, prednisolone, priority journal, reduced folate carrier, repeated drug dose, retrospective study, side effect, skin toxicity | |
dx.doi.org/10.1038/leu.2008.66, hdl.handle.net/1765/15146 | |
Leukemia | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Huang, L, Tissing, W.J.E, de Jonge, R, van Zelst, B.D, & Pieters, R. (2008). Polymorphisms in folate-related genes: Association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia. Leukemia, 22(9), 1798–1800. doi:10.1038/leu.2008.66
|